Stolz LE - Search Results

1

A phase 1 study investigating DX-2930 in healthy subjects.

Chyung Y, Vince B, Iarrobino R, Sexton D, Kenniston J, Faucette R, TenHoor C, Stolz LE, Stevens C, Biedenkapp J, Adelman B. Chyung Y, et al. Among authors: stolz le. Ann Allergy Asthma Immunol. 2014 Oct;113(4):460-6.e2. doi: 10.1016/j.anai.2014.05.028. Epub 2014 Jun 26. Ann Allergy Asthma Immunol. 2014. PMID: 24980392 Free article. Clinical Trial.

2

Characterization of anaphylaxis after ecallantide treatment of hereditary angioedema attacks.

Craig TJ, Li HH, Riedl M, Bernstein JA, Lumry WR, MacGinnitie AJ, Stolz LE, Biedenkapp J, Chyung Y. Craig TJ, et al. Among authors: stolz le. J Allergy Clin Immunol Pract. 2015 Mar-Apr;3(2):206-212.e4. doi: 10.1016/j.jaip.2014.09.001. Epub 2014 Oct 29. J Allergy Clin Immunol Pract. 2015. PMID: 25609335 Free article.

3

Efficacy and safety of ecallantide in treatment of recurrent attacks of hereditary angioedema: open-label continuation study.

Lumry WR, Bernstein JA, Li HH, MacGinnitie AJ, Riedl M, Soteres DF, Craig TJ, Campion M, Iarrobino R, Stolz LE, Pullman WE. Lumry WR, et al. Among authors: stolz le. Allergy Asthma Proc. 2013 Mar-Apr;34(2):155-61. doi: 10.2500/aap.2013.34.3653. Allergy Asthma Proc. 2013. PMID: 23484891 Clinical Trial.

4

Abdominal attacks and treatment in hereditary angioedema with C1-inhibitor deficiency.

Rubinstein E, Stolz LE, Sheffer AL, Stevens C, Bousvaros A. Rubinstein E, et al. Among authors: stolz le. BMC Gastroenterol. 2014 Apr 9;14:71. doi: 10.1186/1471-230X-14-71. BMC Gastroenterol. 2014. PMID: 24712435 Free PMC article. Clinical Trial.

5

Outcomes after ecallantide treatment of laryngeal hereditary angioedema attacks.

Sheffer AL, MacGinnitie AJ, Campion M, Stolz LE, Pullman WE. Sheffer AL, et al. Among authors: stolz le. Ann Allergy Asthma Immunol. 2013 Mar;110(3):184-188.e2. doi: 10.1016/j.anai.2012.12.007. Epub 2013 Jan 5. Ann Allergy Asthma Immunol. 2013. PMID: 23548529 Clinical Trial.

6

Ecallantide: a plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema.

Stolz LE, Horn PT. Stolz LE, et al. Drugs Today (Barc). 2010 Aug;46(8):547-55. doi: 10.1358/dot.2010.46.8.1507205. Drugs Today (Barc). 2010. PMID: 20830315 Review.

7

Prospective, double-blind, placebo-controlled trials of ecallantide for acute attacks of hereditary angioedema.

Stolz LE, Sheffer AL. Stolz LE, et al. Expert Rev Clin Immunol. 2012 Jan;8(1):25-32. doi: 10.1586/eci.11.81. Expert Rev Clin Immunol. 2012. PMID: 22149337 Clinical Trial.

8

Ecallantide for treatment of acute hereditary angioedema attacks: analysis of efficacy by patient characteristics.

MacGinnitie AJ, Campion M, Stolz LE, Pullman WE. MacGinnitie AJ, et al. Among authors: stolz le. Allergy Asthma Proc. 2012 Mar-Apr;33(2):178-85. doi: 10.2500/aap.2012.33.3528. Allergy Asthma Proc. 2012. PMID: 22525395

9

Use of ecallantide in pediatric hereditary angioedema.

MacGinnitie AJ, Davis-Lorton M, Stolz LE, Tachdjian R. MacGinnitie AJ, et al. Among authors: stolz le. Pediatrics. 2013 Aug;132(2):e490-7. doi: 10.1542/peds.2013-0646. Epub 2013 Jul 22. Pediatrics. 2013. PMID: 23878046

10

Blocking FcRn in humans reduces circulating IgG levels and inhibits IgG immune complex-mediated immune responses.

Blumberg LJ, Humphries JE, Jones SD, Pearce LB, Holgate R, Hearn A, Cheung J, Mahmood A, Del Tito B, Graydon JS, Stolz LE, Bitonti A, Purohit S, de Graaf D, Kacena K, Andersen JT, Christianson GJ, Roopenian DC, Hubbard JJ, Gandhi AK, Lasseter K, Pyzik M, Blumberg RS. Blumberg LJ, et al. Among authors: stolz le. Sci Adv. 2019 Dec 18;5(12):eaax9586. doi: 10.1126/sciadv.aax9586. eCollection 2019 Dec. Sci Adv. 2019. PMID: 31897428 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page